Life sciences

#Covid-19 #Life sciences #Synthetic chemistry

£54 million project benefits pre-clinical discovery CRO

Loughborough’s life sciences hub Charnwood Campus in the UK has recommissioned its synthetic and chemistry research facility to cater to the needs of pre-clinical discovery contract research organisation (CRO) Charnwood Molecular. It will cost £54 million. The new laboratories will provide capacity for future growth and expansion of Charnwood Molecular’s medicinal chemistry… Read More

#News

#Biomedical research #Drug discovery #Life sciences

£1 million grant will help develop new medicines in Scotland

The University of Dundee has received £1 million from the Wolfson Foundation to contribute to the costs of fitting-out the Tay Cities Regional Innovation Hub with laboratories and facilities required by high-growth biomedical companies seeking to develop new medicines and medical technologies. The Innovation Hub is central to Growing the… Read More

#News

#Biopharma #Drug discovery #Life sciences #R&D

Abcam opens new US site

Abcam has opened a new site in Waltham, MA. The facility is a central part of Abcam’s growth in the US and will serve as a hub for its R&D and commercial activities in the region. “Abcam’s first step toward global expansion was in 2003 at Kendall Square.  Since then,… Read More

#News

#Biopharmaceuticals #Biotechnology #Covid-19 #Health #Life sciences

UK pharma sees R&D spend hold up despite Brexit and Covid-19

A survey of 75 pharmaceutical, life sciences and medtech businesses indicates R&D spending is being maintained and is set to rise in 2021, despite Brexit and the impact of Covid-19. The survey included SMEs in these sectors in the UK and was conducted by accountancy group MHA. This is positive… Read More

#Business & Investment #News #Trending News #Trends & Analysis

#Covid-19 #Drug delivery #Drug development #Drug discovery #Life sciences #Regulatory #Technology

How will UK life sciences vision impact medicine development and research?

The new UK Life Sciences Vision, developed with businesses and experts in the field, outlines seven critical missions that government, industry, the NHS, academia and medical research charities will work together on at speed to solve – from cancer treatment to tackling dementia. These missions will focus on preventing, diagnosing,… Read More

#News #Regulatory #Trending News

#Biotherapeutics #Clinical trials #Drug discovery #Life sciences

Awakn Life Sciences: new CRO and patent application

Awakn Life Sciences has appointed neuroscientist and addiction researcher, Professor David Nutt as Chief Research Officer as well as announcing the filing of patent applications in the US for two next-generation novel MDMA-derived new chemical entities. This executive appointment is driven by the expansion of Awakn’s psychedelic drug and therapy… Read More

#News

#Antibodies #Complex medicines #Covid-19 #Drug delivery #Drug development #Drug discovery #Drug targets #Life sciences

Financial benefit of complex medicines to UK life sciences

Shaping the UK into an epicentre for complex medicines is a report by the Medicines Discovery Catapult (MDC) in partnership with the CPI, which showcases the potential for the UK in developing complex medicines. The report details the potential medical and economic impact of this field, and how the UK… Read More

#News

#Biomanufacturing #Life sciences #Recruitment

Recruitment: Director of The Stack Family CBET

Albany College of Pharmacy and Health Sciences has an opening for the Director of The Stack Family Centre for Biopharmaceutical Education and Training (CBET). CBET is an evolutionary leap in health sciences education and biomanufacturing workforce training. The CBET Director will be responsible for the development and creation of sustainable… Read More

#News

#Life sciences #Synthetic chemistry

New educational video on synthetic chemistry

Sinocompound Catalysts has launched a video series sharing catalyst expertise. “The essentials in a synthetic chemist’s toolbox”, is the swork of Technical Advisor, Dr Carin Seechurn. The first episode is now live and focuses on palladium catalysed cross-coupling reactions. Over the last 20-30 years, hundreds of ligands have been reported… Read More

#News

#Cell and gene therapy #Cell and Gene Therapy Catapult #Life sciences

Horiba joins cell and gene therapy consortium

Horiba has announced its participation in a new consortium formed to accelerate the development of process analytical technologies (PAT) in cell and gene therapy manufacturing. Horiba’s new A-TEEM Molecular Fingerprinting technology has shown great promise for fast QC/QA of complex biological systems and is a core technology being assessed for… Read More

#News

#Biopharmaceuticals #Life sciences #Pharma #STEM

Lab To Leadership: inspiring leaders in STEM

Aly King-Smith is Director of Clearworks, based at the historic Caswell Science Park in Northamptonshire. King-Smith speaks with DDW’s Megan Thomas about Clearworks’ Lab To Leadership initiative, established to inspire leaders in STEM. MT: Could you provide a general overview of the course and the company behind it? AKS: Lab… Read More

#Exclusive Content #News

#Corning Life Sciences #Drug screening #Events #Life sciences #Tumour biology

Corning Life Sciences to host a virtual 3D Cell Culture Summit

Corning Life Sciences will be hosting a virtual 3D Cell Culture Summit, June 16-17, that will bring together industry leaders and innovators to share ideas and information, and to discuss the future of 3D applications including spheroid, organoid and tissue models 3D workflow optimisation, trends, and innovation. Some of… Read More

#News

#Biology #Biotechnology #Drug development #Drug discovery #Life sciences #SLAS 2021

Poster award deadlines approaching for SLAS 2021

The deadlines for the Tony B. Academic Award and the Student Poster Award for SLAS Europe 2021 is June 14, a week prior to the conference, which takes place June 23-25 digitally. SLAS’ call for poster abstracts provide opportunities to receive recognition, experience and praise for original research by a… Read More

#News

#Biosciences #Life sciences #Mental health #Psychedelics

Early success on psychedelic healthcare investments

Neo Kuma Ventures has invested in seven innovative healthcare companies. The initial investments have proved successful with three of the seven companies going public this year, yielding between +180% and +680% return on initial investment. Following the launch of its fund in December 2020, Neo Kuma has invested more than… Read More

#News

#Antibodies #Drug development #Life sciences

Picking the right custom antibody provider

Selecting the right custom antibody provider for a project is an important decision. It can mean the difference between a breakthrough or failure. It is therefore important where and how antibodies are made. With this infographic, available for free download, you will learn what sets Fortis Life Science’s Bethyl… Read More

#Editor's Choice #News

#3D modelling #Assay development optimisation & technology #Corning Life Sciences #Drug efficacy #Life sciences

All-in-one solution for the development of 3D liver models

The HepGo Assay-ready 3D Liver Spheroid Kit leverages Corning Life Science’s 3D cell culture technology in liver biology and ADME/Tox. Corning has developed an all-in-one solution for the development of 3D liver models that has been designed to better recapitulate in vivo behaviour. The kit is said to deliver a… Read More

#News